Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;25(1):31-36.
doi: 10.1038/ejhg.2016.132. Epub 2016 Oct 5.

Biobank attributes associated with higher patient participation: a randomized study

Affiliations

Biobank attributes associated with higher patient participation: a randomized study

Angèle Gayet-Ageron et al. Eur J Hum Genet. 2016 Jan.

Abstract

The objectives of the study were to assess patients' intent to participate in a hospital-based biobank and to explore the factors associated with higher participation. A 23-item questionnaire was developed to survey a random sample of patients in a Swiss university hospital. Two vignettes describing hypothetical biobanks were incorporated in the survey and patients were asked whether they would agree to participate. Three factors were randomly manipulated in each vignette using a factorial design: cancer-oriented research vs general consent, one vs several reviews of the patient's chart, and genetic vs blood protein analyses (first vignette); blood sample vs oral swabbing, local vs international project, and a follow-up visit vs no visit (second vignette). Of the 1140 respondents, 73.6 and 69.6%, respectively, agreed to participate in the biobank. Biospecimen collection via oral swabbing, single chart review, and no follow-up were associated with higher participation. Participation was also higher among younger patients, Europeans, patients who had a positive opinion on research, and blood/organ donors. Biobanking was supported by a majority of patients, especially if biospecimens were collected through non-invasive techniques or if data collection was done once. The scope of consent, the scale of the project, or the tests performed on biospecimens did not influence participation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of the percentage of answers from certain refusal to certain approval in the first vignette (a) and second vignette (b).

Similar articles

Cited by

References

    1. Khoury MJ, Millikan R, Little J, Gwinn M: The emergence of epidemiology in the genomics age. Int J Epidemiol 2004; 33: 936–944. - PubMed
    1. Ashburn TT, Wilson SK, Eisenstein BI: Human tissue research in the genomic era of medicine: balancing individual and societal interests. Arch Intern Med 2000; 160: 3377–3384. - PubMed
    1. Hofmann B: Broadening consent—-and diluting ethics? J Med Ethics 2009; 35: 125–129. - PubMed
    1. Mooser V, Currat C: The Lausanne Institutional Biobank: a new resource to catalyse research in personalised medicine and pharmaceutical sciences. Swiss Med Wkly 2014; 144: w14033. - PubMed
    1. Master Z, Claudio JO, Rachul C, Wang JC, Minden MD, Caulfield T: Cancer patient perceptions on the ethical and legal issues related to biobanking. BMC Med Genomics 2013; 6: 8. - PMC - PubMed